One trade name, several different plants. “Rhodiola” is sold as Rhodiola rosea, but also as Rhodiola crenulata and other species that are chemically distinct and cheaper. Accepting the wrong one — or a blend — against a loose specification is a costly and entirely avoidable procurement error. Here is how to keep them straight, and why the rosavin number is your single best test.
Several Species, One Trade Name
The genus Rhodiola contains many species, and more than one reaches the extract market. The clinically studied and most-valued is Rhodiola rosea. The most common substitute is Rhodiola crenulata — more available from some regions and generally cheaper — along with occasional appearances of other species. They share a genus and a marketing name, but not a chemistry. For a buyer, the trade name is not a specification: you need the botanical species confirmed.
Rhodiola rosea — The Studied Adaptogen
Rhodiola rosea is standardised to both rosavins and salidroside, classically around a 3:1 ratio (3% rosavins / 1% salidroside). The rosavins — rosavin, rosarin and rosin — are the compounds that distinguish it, and the human clinical evidence on fatigue and stress is built on rosavin-standardised material — see rosavins & salidroside: the research.
Rhodiola crenulata — Salidroside-Led
Rhodiola crenulata contains salidroside but little or no rosavin. It is a legitimate plant with its own traditional use, but it is not interchangeable with R. rosea, and it cannot support a rosavin claim or match the R. rosea trial evidence. Sold transparently as crenulata it is fine; sold as “rhodiola” against a salidroside-only number, it is a substitution.
The Rosavin Test: One Marker Settles It
This is the crux, and it is simple: only Rhodiola rosea carries the rosavin group. A meaningful total-rosavins figure, quantified by HPLC, is therefore both a potency measure and an authenticity test in a single number. Material that reports a healthy salidroside but negligible rosavin is, by definition, not standardised R. rosea — whatever the label says.
- Rhodiola rosea — rosavins present (rosavin, rosarin, rosin) and salidroside; roughly 3:1.
- Rhodiola crenulata — salidroside present, rosavins negligible.
How to Tell Them Apart on Paper
- Botanical name — require Rhodiola rosea L. explicitly; reject a CoA that only says “Rhodiola.”
- Marker set — a stated rosavin percentage, not salidroside alone.
- Identity method — TLC/HPLC fingerprint matched to an R. rosea reference.
- Ratio — a defined rosavins-to-salidroside ratio, close to 3:1 for the classic grade.
Why the Mix-up Happens — and What It Costs
The price and availability of the species differ, which creates room for substitution — intentional or not. The cost of getting it wrong is real: a failed identity test at incoming goods, a mislabelled finished product, a formulation that cannot match its clinical positioning, or a misbranding problem if the label species is not what is in the capsule. In regulated markets, none of it is recoverable once product ships. A salidroside-only specification is precisely the gap that lets it happen — see rosavins & salidroside by HPLC.
Specifying Correctly
State the botanical name, both markers, the assay method and the ratio in your RFQ and on every PO, and qualify the first batch against an R. rosea reference. SV Botanica supplies authenticated Rhodiola rosea, standardised to 3% rosavins and 1% salidroside by HPLC and identity-confirmed on every batch — so there is never ambiguity about which species you are buying. For the full purchase spec, see the Rhodiola extract buyer’s guide.
Need Certainty on Species Identity?
Authenticated Rhodiola rosea · rosavin-standardised · HPLC dual-marker every batch · identity confirmed against reference